Andas

Recent Highlights

Alembic Pharma looks to file 100 ANDAs in US in next 3 yrs

Alembic Pharma looks to file 100 ANDAs in US in next 3 yrs

Sun Pharma Q3 profit dips 5% to Rs 1,472 crore; co to focus on existing business

Sun Pharma arm seeks USFDA nod for voluntary withdrawal of 28 ANDAs of Ranbaxy

Natco Pharma to file over 10 ANDAs in US in next 2 fiscals

All Stories for Andas

Jubilant Life receives USFDA nod for hypertension tablets
• 9 years ago
As on 30 June, 2016, Jubilant Life Sciences had a total of 770 filings for Oral Solids of which 578 have been approved in various regions globally
Zydus Healthcare strengthens US portfolio with 2 ANDA buys from Teva
• 9 years ago
The company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC and will be financed through the group's internal accruals

US agencies knock bottom out of Ranbaxy's future blockbusters
Shishir Asthana • 13 years ago
Ranbaxy's future blockbuster drugs may have been compromised by a settlement with US prosecutors for sale of adulterated drugs

Home Video Shorts Live TV